-
Je něco špatně v tomto záznamu ?
Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells
K. Kuželová, D. Grebeňová, A. Holoubek, P. Röselová, A. Obr,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- apoptóza účinky léků MeSH
- buněčná adheze účinky léků MeSH
- disulfidy metabolismus farmakologie MeSH
- faktory depolymerizující aktin chemie metabolismus MeSH
- fibronektiny metabolismus MeSH
- fosforylace účinky léků MeSH
- hematopoéza účinky léků MeSH
- inhibitory proteinkinas metabolismus farmakologie MeSH
- intracelulární prostor účinky léků metabolismus MeSH
- krevní buňky cytologie účinky léků MeSH
- leukemie patologie MeSH
- lidé MeSH
- lymfom patologie MeSH
- malá interferující RNA genetika MeSH
- naftoly metabolismus farmakologie MeSH
- p21 aktivované kinasy antagonisté a inhibitory nedostatek genetika MeSH
- proliferace buněk účinky léků MeSH
- regulace genové exprese účinky léků MeSH
- serin metabolismus MeSH
- umlčování genů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 μM. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 μM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014452
- 003
- CZ-PrNML
- 005
- 20150421092158.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0092560 $2 doi
- 035 __
- $a (PubMed)24664099
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kuželová, Kateřina $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 245 10
- $a Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells / $c K. Kuželová, D. Grebeňová, A. Holoubek, P. Röselová, A. Obr,
- 520 9_
- $a P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 μM. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 μM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.
- 650 _2
- $a faktory depolymerizující aktin $x chemie $x metabolismus $7 D051339
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a krevní buňky $x cytologie $x účinky léků $7 D001773
- 650 _2
- $a buněčná adheze $x účinky léků $7 D002448
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a disulfidy $x metabolismus $x farmakologie $7 D004220
- 650 _2
- $a fibronektiny $x metabolismus $7 D005353
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a umlčování genů $7 D020868
- 650 _2
- $a hematopoéza $x účinky léků $7 D006410
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intracelulární prostor $x účinky léků $x metabolismus $7 D042541
- 650 _2
- $a leukemie $x patologie $7 D007938
- 650 _2
- $a lymfom $x patologie $7 D008223
- 650 _2
- $a naftoly $x metabolismus $x farmakologie $7 D009284
- 650 _2
- $a fosforylace $x účinky léků $7 D010766
- 650 _2
- $a inhibitory proteinkinas $x metabolismus $x farmakologie $7 D047428
- 650 _2
- $a malá interferující RNA $x genetika $7 D034741
- 650 _2
- $a serin $x metabolismus $7 D012694
- 650 _2
- $a p21 aktivované kinasy $x antagonisté a inhibitory $x nedostatek $x genetika $7 D054462
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Grebeňová, Dana $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Holoubek, Aleš $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Röselová, Pavla $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Obr, Adam $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 3 (2014), s. e92560
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24664099 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150421092456 $b ABA008
- 999 __
- $a ok $b bmc $g 1072033 $s 897330
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 9 $c 3 $d e92560 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20150420